Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels
Titel:
Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels
Auteur:
Dobi, Anthony Dubernet, Arthur Rakoto, Mahary Lalarizo Seteyen, Anne-Laure Sandenon Vagner, Damien Lebeau, Grégorie Raffray, Loïc Gasque, Philippe